Catalyst Event
Amgen Inc (AMGN) · Other
From KEDI U.S. Dividend100 90% Participation + Daily Options Premium Index (KUSDV100P)
4/28/2026, 12:00:00 AM
On April 28, 2026, the FDA announced Amgen's participation in a new proof-of-concept pilot for real-time clinical trials (RTCT) for Imdelltra. Low importance is estimated as this is a procedural pilot program.
Korean Translation
2026년 4월 28일, FDA의 실시간 임상시험(RTCT) 시범 프로그램에 임델트라(Imdelltra) 연구가 참여한다고 발표함. 절차적 시범 프로그램 참여로 낮은 중요도로 예상함.
Related Recent Events
Procter & Gamble Co (The) (PG) · Earnings Release
Analysts forecast Procter & Gamble to release its Q4 2026 earnings report on August 4, 2026, forecasted. Low impact is estimated as the announcement date itself typically has minimal immediate price effect.
8/4/2026, 12:00:00 AM
Kforce Inc (KFRC) · Other
Quarterly dividend of $0.40 per share, ex-dividend date is June 12, 2026 scheduled
6/12/2026, 12:00:00 AM
DICK'S Sporting Goods Inc (DKS) · Earnings Release
Medium importance is estimated due to the historical impact of quarterly earnings on stock volatility. Q1 2026 earnings release is scheduled.
5/27/2026, 12:00:00 AM
Booz Allen Hamilton Holding Corporation (BAH) · Earnings Release
Fourth quarter and full fiscal year 2026 earnings results for the period ending March 31, 2026 are scheduled.
5/22/2026, 12:00:00 AM
Home Depot Inc. (The) (HD) · Other
The Annual Meeting of Shareholders is scheduled for May 21, 2026. Low importance estimated as annual meetings typically result in 1-5% price impact, scheduled.
5/21/2026, 12:00:00 AM
Target Corp (TGT) · Earnings Release
Target is scheduled to release its Q1 2026 earnings on May 20, 2026. Analysts forecast EPS of approximately $1.34. This is a future event, and importance is estimated as High due to the potential for significant price movement based on results and updated guidance scheduled
5/20/2026, 12:00:00 AM